CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for VJGJ, INC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

VJGJ, INC
105 Lincoln Avenue
Phone: (856) 697-1441p:856 697-1441 BUENA, NJ  08310  United States Fax: (856) 697-1442f:856 697-1442
Emerged from Bankruptcy on 7/26/2022
This company is no longer actively traded on any major stock exchange.
Business Summary
VJGJ, INC, formerly doing business as Teligent, Inc., is a generic pharmaceutical company. The Company is focused on the development, manufacturing and marketing of a portfolio of generic pharmaceutical products under its own label and private label for other pharmaceutical companies in topical, injectable, complex and other dosage forms. It also provides contract development and manufacturing services to the prescription and over-the-counter (OTC) pharmaceutical and cosmetic markets. Under the Company's own label, it markets and sells generic topical, and generic and branded generic injectable pharmaceutical products in the United States. In the United States, the Company markets approximately 37 generic topical pharmaceutical products and one branded injectable pharmaceutical product. The Company's portfolio of hospital-based sterile injectable products, including cephalosporins, Cefotan (Cefotetan for Injection), Fortaz (Ceftazidime) and Zinacef (Cefuroxime Sodium).

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202112/31/2020YesYesYesYes-

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
2834 Pharmaceutical preparations
3845 Electromedical and electrotherapeutic apparatus
2844 Perfumes, cosmetics, and other toilet preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board John E.Celentano 61 7/20/2020 3/23/2015
Interim Chief Financial Officer AlyssaLozynski 31 9/29/2021 9/29/2021
Chief Restructuring Officer VladimirKasparov 40 10/14/2021 10/14/2021
3 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Teligent Pharma, Inc. 33 Wood Avenue Iselin NJ United States

Business Names
Business Name
Alveda Pharmaceuticals, Inc.
Blood Cells, Inc.
Flavorsome, Ltd.
15 additional Business Names available in full report.

General Information
Outstanding Shares: 92,817,493 (As of 8/12/2021)
Shareholders: 46
Stock Exchange: OTC
Federal Tax Id: 010355758
Fax Number: (856) 697-1442


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, April 1, 2024